Statistics published today in the UK by the Department of Health, the Office of Life Sciences and the Department for Business, reveal a mixed picture with an overall modest increase in life sciences economic activity in the ten years from 2009 to 2018.
Ablacon, which is developing an atrial fibrillation (AFib) mapping system, has closed a $21.5 million Series A funding round led by Ajax Health.
908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, has raised a $17.5 million Series E financing round led by Northpond Ventures.
The World Health Organisation (WHO) has published a guideline for the use of digital health interventions to strengthen health systems.
Redox, which enables healthcare data exchange, has closed a $33 million Series C funding round, led by Battery Ventures.
Sonde Health, which is developing a voice-based diagnostics platform, has secured $16 million in a Series A financing round led by M Ventures, with MP Healthcare Venture Management, Neoteny 4, LP, Canepa Healthcare, and founder PureTech Health
Researchers at the University of Oxford, the University of Westminster and Perspectum Diagnostics have shown that effective assessment of the health of the liver can be done non-invasively using MRI-based imaging.
Signum Surgical, which is developing minimally invasive technologies to treat colorectal diseases, has secured two grants totalling €3.6 million: €2.3 million from the EU Horizon 2020 SME Instrument, and €1.3 million from Ireland’s Disruptive Technologies Innovation Fund.
Deep Lens, an AI-enabled clinical trial recruitment platform, has closed a $14 million Series A round led by Northpond Ventures, with participation from existing investors Rev1 Ventures, Sierra Ventures, and Tamarind-Hill Partners.
A collaboration between Sweati and Imperial College London has demonstrated a device that is capable of continuous monitoring of glucose, lactate and hydration.